BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36539366)

  • 61. MiR-122-5p suppresses cell proliferation, migration and invasion by targeting SATB1 in nasopharyngeal carcinoma.
    Liu YH; Liu JL; Wang Z; Zhu XH; Chen XB; Wang MQ
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):622-629. PubMed ID: 30720170
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Methyltransferase-like 3-mediated m6A modification of miR-1908-5p contributes to nasopharyngeal carcinoma progression by targeting homeodomain-only protein homeobox.
    Zhou Y; Li W
    Environ Toxicol; 2024 Mar; 39(3):1631-1640. PubMed ID: 38018881
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MiR-122-5p regulates erastin-induced ferroptosis via CS in nasopharyngeal carcinoma.
    Guo L; Wang Z; Fu Y; Wu S; Zhu Y; Yuan J; Liu Y
    Sci Rep; 2024 May; 14(1):10019. PubMed ID: 38693171
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Non-Coding RNA Pvt1 Promotes Cancer Stem Cell-Like Traits in Nasopharyngeal Cancer via Inhibiting miR-1207.
    Cui M; Chang Y; Fang QG; Du W; Wu JF; Wang JH; Liu ST; Luo SX
    Pathol Oncol Res; 2019 Oct; 25(4):1411-1422. PubMed ID: 30141114
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
    Li T; Li Y
    Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
    [TBL] [Abstract][Full Text] [Related]  

  • 66. miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin.
    Zhen Y; Fang W; Zhao M; Luo R; Liu Y; Fu Q; Chen Y; Cheng C; Zhang Y; Liu Z
    Oncogene; 2017 Jan; 36(2):275-285. PubMed ID: 27270423
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IncRNA ZFAS1 contributes to the radioresistance of nasopharyngeal carcinoma cells by sponging hsa-miR-7-5p to upregulate ENO2.
    Peng J; Liu F; Zheng H; Wu Q; Liu S
    Cell Cycle; 2021 Jan; 20(1):126-141. PubMed ID: 33342344
    [TBL] [Abstract][Full Text] [Related]  

  • 68. LINC00240 knockdown inhibits nasopharyngeal carcinoma progress by targeting miR-26a-5p.
    Chen X; Wu G; Qing J; Li C; Chen X; Shen J
    J Clin Lab Anal; 2022 May; 36(5):e24424. PubMed ID: 35421264
    [TBL] [Abstract][Full Text] [Related]  

  • 69. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 70. miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1.
    Jia-Yuan X; Wei S; Fang-Fang L; Zhi-Jian D; Long-He C; Sen L
    Biomed Res Int; 2020; 2020():9704245. PubMed ID: 32280708
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.
    Liu Z; Cheng C; Luo X; Xia Q; Zhang Y; Long X; Jiang Q; Fang W
    BMC Cancer; 2016 Mar; 16():238. PubMed ID: 26993269
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Upregulation of Insulin-Like Growth Factor-1 Receptor (IGF-1R) Reverses the Inhibitory Effect of Let-7g-5p on Migration and Invasion of Nasopharyngeal Carcinoma.
    Zhao Z; Wen J; Peng L; Liu H
    Med Sci Monit; 2019 Aug; 25():5747-5756. PubMed ID: 31374070
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway.
    Lv B; Li F; Liu X; Lin L
    Cancer Gene Ther; 2021 Feb; 28(1-2):74-88. PubMed ID: 32555352
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
    Jiang C; Cheng Z; Jiang T; Xu Y; Wang B
    Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
    [TBL] [Abstract][Full Text] [Related]  

  • 75. miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma.
    Liu Y; Zhao R; Wang H; Luo Y; Wang X; Niu W; Zhou Y; Wen Q; Fan S; Li X; Xiong W; Ma J; Li X; Tan M; Li G; Zhou M
    Cell Death Dis; 2016 Mar; 7(3):e2156. PubMed ID: 27010857
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinoma.
    Wan FZ; Chen KH; Sun YC; Chen XC; Liang RB; Chen L; Zhu XD
    J Transl Med; 2020 Jan; 18(1):12. PubMed ID: 31915008
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CircCRIM1 promotes nasopharyngeal carcinoma progression via the miR-34c-5p/FOSL1 axis.
    He W; Zhou X; Mao Y; Wu Y; Tang X; Yan S; Tang S
    Eur J Med Res; 2022 Apr; 27(1):59. PubMed ID: 35484574
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Down-regulated long non-coding RNA LHFPL3 antisense RNA 1 inhibits the radiotherapy resistance of nasopharyngeal carcinoma via modulating microRNA-143-5p/homeobox A6 axis.
    Wang W; Zhang Z; Li Y; Gu A; Wang Y; Cai Y; Yu Y; Deng X
    Bioengineered; 2022 Mar; 13(3):5421-5433. PubMed ID: 35176945
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p.
    Zhu L; Liu Y; Yang Y; Mao XM; Yin ZD
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2817-2826. PubMed ID: 31002133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.